Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine erector spinae block for pain after lumbar laminectomy
IRCT20251216068353N1Phase 3Recruiting
- Sponsor
- Babol University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Postoperative lumbar pain intensity. Started Jan 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20251216068353N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251216068353N1.